Stem Cell Research (Jun 2023)

Generation of two induced pluripotent stem cell lines from spinal muscular atrophy type 1 patients carrying no functional copies of SMN1 gene

  • Wenshu Zeng,
  • Xiaohui Kong,
  • Christina Alamana,
  • Yu Liu,
  • Jessica Guzman,
  • Paul D. Pang,
  • John W. Day,
  • Joseph C. Wu

Journal volume & issue
Vol. 69
p. 103095

Abstract

Read online

Spinal muscular atrophy (SMA) is a severe neurodegenerative muscular disease caused by the homozygous loss of survival of motor neuron 1 (SMN1) genes. SMA patients exhibit marked skeletal muscle (SKM) loss, eventually leading to death. Here we generated two iPSC lines from two SMA type I patients with homozygous SMN1 mutations and validated the pluripotency and the ability to differentiate into three germ layers. The iPSC lines can be applied to generate skeletal muscles to model muscle atrophy of SMA that persists after treatment of motor neurons and will serve as a complementary platform for drug screening in vitro.

Keywords